Anaerobe Bio

Anaerobe Bio

厌氧生物

Anaerobe Bio

Biotech/Healthcare

Anaerobic Bio develops microbiome-based therapeutics. It has end-to-end core technologies for anaerobic microbial drug development, including high-throughput screening of anaerobic microorganisms, efficient evaluation of live biotherapeutics, and live-strain storage and transportation.

Latest round: Series B (2026)

Source: ChinaBulls — chinabulls.com

Last updated 2026-01-01

Funding history

Request access to view this section.

Investors

Request access to view this section.

HQ & website

Request access to view this section.

Tags

Request access to view this section.